Last updated: January 24, 2023
Sponsor: Yonsei University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Depression
Treatment
N/AClinical Study ID
NCT05539131
2022-0225-002
Ages 19-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male and Female aged 19 to 65 with mild and moderate Major depressive disorder (MDD)
Exclusion
Exclusion Criteria:
- Those diagnosed with Post-traumatic stress disorder (PTSD), Obsessive compulsivedisorder (OCD), bipolar or psychotic major depressive disorder, high suicide risk,Electroencephalography (EEG) and DC stimulation electrode attachment problems (such asscalp deformity, inflammatory response or other dermatological problems), Transcranialdirect current stimulation (tDCS) medical device taboos (such as head metal plateinsertion), clinical trials that have been inadequate for clinical trials
Study Design
Total Participants: 198
Study Start date:
November 04, 2022
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
Hallym Univsity Chuncheon Sacred Heart Hospital
Chuncheon, Gangwon 24253
Korea, Republic ofActive - Recruiting
Myongji Hospital
Goyang, Gyeonggi 10475
Korea, Republic ofActive - Recruiting
National Health Insurance Service Ilsanhospital
Goyang, Gyeonggi 10444
Korea, Republic ofActive - Recruiting
Catholic Kwandong University International St. Mary'S Hospital
Incheon, Gyeonggi 22711
Korea, Republic ofActive - Recruiting
Yongin Severance Hospital, Yonsei University College of Medicine
Yongin, Gyeonggi 16995
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.